Alcon Stock ALC.SW
Price
Alcon stock price
Details
Price
ⓘOverview
The Quote Chart provides detailed and dynamic insights into the Alcon stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.
Intraday Feature
The intraday feature provides real-time data, allowing investors to view the Alcon stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.
Total Return and Relative Price Change
View the total return of the Alcon stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.
Interpretation and Investment
Utilize the comprehensive data presented in the Quote Chart to analyze Alcon's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.
| Date | Alcon Price |
|---|---|
| 2/20/2026 | 82.47 USD |
| 2/19/2026 | 81.61 USD |
| 2/18/2026 | 81.51 USD |
| 2/17/2026 | 81.00 USD |
| 2/16/2026 | 79.38 USD |
| 2/13/2026 | 79.14 USD |
| 2/12/2026 | 77.96 USD |
| 2/11/2026 | 79.42 USD |
| 2/10/2026 | 80.21 USD |
| 2/9/2026 | 78.49 USD |
| 2/6/2026 | 78.44 USD |
| 2/5/2026 | 79.04 USD |
| 2/4/2026 | 79.17 USD |
| 2/3/2026 | 77.02 USD |
| 2/2/2026 | 80.62 USD |
| 1/30/2026 | 80.90 USD |
| 1/29/2026 | 80.70 USD |
| 1/28/2026 | 81.24 USD |
| 1/27/2026 | 81.00 USD |
| 1/26/2026 | 80.85 USD |
| 1/23/2026 | 81.99 USD |
| 1/22/2026 | 81.28 USD |
Alcon Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Alcon Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (B USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | 2029e | 2030e | 2031e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.6 | 6.79 | 7.15 | 7.51 | 6.83 | 8.29 | 8.72 | 9.46 | 9.91 | 10.48 | 11.25 | 11.99 | 12.59 | 13.43 | 14.19 | 14.65 |
| – | 2.97 | 5.32 | 4.96 | -8.99 | 21.34 | 5.14 | 8.47 | 4.82 | 5.70 | 7.36 | 6.62 | 4.98 | 6.66 | 5.70 | 3.21 |
| 47.45 | 47.17 | 49.90 | 48.69 | 45.24 | 56.64 | 55.17 | 55.57 | 55.65 | 52.64 | 49.04 | 45.99 | 43.81 | 41.07 | 38.86 | 37.65 |
| 3.13 | 3.2 | 3.57 | 3.66 | 3.09 | 4.7 | 4.81 | 5.25 | 5.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -0.17 | 0.26 | -0.23 | -0.66 | -0.53 | 0.38 | 0.34 | 0.97 | 1.02 | 1.53 | 1.71 | 1.99 | 2.25 | 2.59 | 2.79 | 0 |
| – | -250.59 | -188.67 | 188.99 | -19.05 | -170.81 | -10.90 | 190.75 | 4.52 | 50.39 | 11.69 | 16.55 | 12.79 | 14.99 | 8.05 | – |
| - | - | - | - | - | 0.10 | 0.20 | 0.21 | 0.48 | 0.28 | 0.76 | 0.90 | 1.04 | 1.17 | 1.27 | - |
| – | – | – | – | – | – | 100.00 | 5.00 | 128.57 | -41.67 | 171.43 | 18.42 | 15.56 | 12.50 | 8.55 | – |
| 488.7 | 488.7 | 488.7 | 488.2 | 489 | 493.4 | 494.4 | 496.5 | 497.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Details
Keystats
ⓘRevenue and Growth
The Alcon Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Alcon is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
Alcon Stock Quarterly Figures
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| 2018 Q2 | 2018 Q3 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4e | 2026 Q1e | 2026 Q2e | 2026 Q3e | 2026 Q4e | 2027 Q1e | 2027 Q2e | 2027 Q3e | 2027 Q4e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.82 | 1.76 | 1.9 | 1.87 | 1.91 | 1.84 | 1.21 | 1.84 | 1.94 | 1.93 | 2.11 | 2.1 | 2.15 | 2.19 | 2.22 | 2.14 | 2.17 | 2.35 | 2.42 | 2.33 | 2.35 | 2.46 | 2.5 | 2.45 | 2.5 | 2.47 | 2.6 | 2.61 | 2.74 | 2.74 | 2.81 | 2.79 | 2.93 | 2.95 | 2.95 | 2.94 | 3.13 |
| – | -3.19 | 8.00 | -1.84 | 2.41 | -3.76 | -34.06 | 51.40 | 5.55 | -0.52 | 9.33 | -0.38 | 2.24 | 1.86 | 1.28 | -3.47 | 1.45 | 8.34 | 2.98 | -3.84 | 0.99 | 4.55 | 1.50 | -1.68 | 1.96 | -1.16 | 4.97 | 0.69 | 4.93 | -0.22 | 2.63 | -0.57 | 4.80 | 0.82 | 0.03 | -0.30 | 6.32 |
| 48.24 | 32.24 | 50.03 | 49.41 | 48.14 | 47.85 | 33.28 | 47.12 | 48.45 | 55.75 | 57.82 | 56.80 | 56.12 | 55.60 | 56.43 | 54.58 | 54.03 | 55.65 | 56.48 | 55.52 | 54.59 | 56.32 | 55.05 | 55.87 | 55.36 | 50.71 | 55.08 | 55.74 | 53.12 | 53.23 | 51.87 | 52.17 | 49.78 | 49.37 | 49.36 | 49.51 | 46.56 |
| 0.88 | 0.57 | 0.95 | 0.92 | 0.92 | 0.88 | 0.4 | 0.87 | 0.94 | 1.08 | 1.22 | 1.19 | 1.21 | 1.22 | 1.25 | 1.17 | 1.17 | 1.31 | 1.37 | 1.29 | 1.28 | 1.39 | 1.37 | 1.37 | 1.39 | 1.25 | 1.43 | 1.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 15 | -207 | -390 | -66 | -91 | -57 | -422 | -147 | 95 | 84 | 151 | 2 | 139 | 168 | 148 | 116 | -97 | 174 | 169 | 204 | 427 | 248 | 223 | 263 | 284 | 350 | 176 | 237 | 394 | 422 | 412 | 434 | 461 | 512 | 497 | 517 | 532 |
| – | -1,480.00 | 88.41 | -83.08 | 37.88 | -37.36 | 640.35 | -65.17 | -164.63 | -11.58 | 79.76 | -98.68 | 6,850.00 | 20.86 | -11.90 | -21.62 | -183.62 | -279.38 | -2.87 | 20.71 | 109.31 | -41.92 | -10.08 | 17.94 | 7.98 | 23.24 | -49.71 | 34.66 | 66.24 | 7.11 | -2.37 | 5.34 | 6.22 | 11.06 | -2.93 | 4.02 | 2.90 |
| - | - | - | - | - | - | - | - | - | 0.10 | - | - | - | 0.20 | - | - | - | 0.21 | - | - | - | 0.24 | - | - | - | 0.28 | - | - | - | - | - | - | - | - | - | - | - |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 488.2 | 488.2 | 488.2 | 488.2 | 488.2 | 488.6 | 489 | 489.1 | 489.3 | 492.8 | 493.2 | 493.8 | 494 | 494 | 494.3 | 494.7 | 491.4 | 495.5 | 495.7 | 496.3 | 497.1 | 496.6 | 497 | 497.7 | 498.4 | 498 | 495.2 | 495.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Details
Keystats
ⓘRevenue and Growth
The Alcon Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Alcon is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
Alcon stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Alcon Stock Sales Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Alcon business model
Alcon SWOT Analysis
Strengths
Alcon AG has a strong global presence in the ophthalmic pharmaceuticals and medical devices market.
The company has a diverse portfolio of innovative products, enabling it to cater to various eye care needs.
Alcon AG possesses strong research and development capabilities, allowing for the development of cutting-edge technologies and advancements in eye care.
Weaknesses
Alcon AG faces intense competition from both established players and emerging companies in the ophthalmic industry.
The company has a high dependence on a few key products, which exposes it to the risk of market fluctuations.
Alcon AG's profitability may be affected by the need for significant investments in research and development.
Opportunities
The global demand for eye care products and services is expected to increase due to an aging population and rising prevalence of eye-related disorders.
Alcon AG can explore expanding its presence in emerging markets, where the demand for eye care products is growing rapidly.
The company can leverage technological advancements to develop innovative products and gain a competitive edge.
Threats
Changing regulations and government policies in the healthcare industry pose a threat to Alcon AG's operations and profitability.
The company may face challenges in effectively managing and protecting its intellectual property rights.
Alcon AG is exposed to the risk of product recalls, which can significantly damage its reputation and financial performance.
Alcon Eulerpool Fair Value
Details
Fair Value
ⓘUnderstanding Fair Value
The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.
Income-Based Fair Value
This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.
Example 2022
Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)
Revenue-Based Fair Value
It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.
Example 2022
Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)
Dividend-Based Fair Value
This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.
Example 2022
Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)
Expectations and Forecasts
Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.
Comparative Analysis
Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.
Alcon historical P/E ratio, EBIT multiple, and P/S ratio
Details
Historical valuation
ⓘHistorical Price Earnings Ratio (P/E)
The Historical Price Earnings Ratio (P/E) is a key metric that illustrates the relationship between a Alcon's share price and its earnings per share (EPS). It helps investors understand how much they are paying for a company’s earning capacity. A lower P/E ratio might indicate that the stock is undervalued, while a higher ratio can suggest overvaluation, all else being equal.
Price to Revenue Ratio (P/R)
The Price to Revenue Ratio (P/R) of Alcon is calculated by dividing the current stock price by the revenue per share. This ratio offers insights into the value investors are willing to pay for each dollar of revenue generated. It is especially useful for valuing companies that are not yet profitable or have erratic earnings.
Price to EBIT Ratio (P/EBIT)
The Price to EBIT Ratio compares the Alcon's market capitalization to its earnings before interest and taxes (EBIT). This ratio provides insights into a company’s profitability and operational efficiency, excluding the impacts of tax and capital structure. It is a valuable tool for comparing companies in the same industry.
Interpretation and Use
These ratios are integral in assessing a company’s valuation and profitability. Investors utilize these metrics to make informed decisions, comparing Alcon’s financial performance and market valuation against historical data, industry averages, and competitors. They aid in identifying potential investment opportunities and risks, contributing to a comprehensive investment strategy.
Alcon annual returns
Details
Annual Return
ⓘUnderstanding the Rendite Chart
The rendite chart provides a comprehensive view of the annual return on investment for . It is divided into two parts - stock price rendite and dividend rendite, offering insights into the overall performance and profitability of the investment.
Stock Price Rendite
This section represents the annual return due to the appreciation or depreciation of the 's stock price. Analyzing this data can help investors understand the stock’s historical performance and predict future trends.
Dividend Rendite
Dividend rendite showcases the percentage return on investment from dividends paid out by . It is a key indicator for investors looking for income generation in addition to stock price appreciation.
Making Investment Decisions
By evaluating both the stock price and dividend rendite, investors can gain insights into the total return on investment. It aids in making informed decisions, balancing between growth and income investment strategies.
Alcon shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Alcon dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Alcon dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
| Δ MOM Price Target | 0 % |
| Buy | 75.00 % (15) |
| Hold | 15.00 % (3) |
| Sell | 10.00 % (2) |
| 12M Price Target | 107.70 |
| Last Price | 68.40 |
| Currency | USD |
| 12M Return Potential | 57.46 % |
| LTM Return | 0 % |
Alcon Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 2/26/2024 | 0.68USD | 2.37 BUSD | 2023 Q4 |
| 8/7/2023 | 0.68USD | 2.34 BUSD | 2023 Q2 |
| 2/14/2023 | 0.45USD | 2.23 BUSD | 2022 Q4 |
| 11/15/2022 | 0.51USD | 2.17 BUSD | 2022 Q3 |
| 8/9/2022 | 0.57USD | 2.24 BUSD | 2022 Q2 |
| 5/9/2022 | 0.55USD | 2.07 BUSD | 2022 Q1 |
| 2/15/2022 | 0.5USD | 2.12 BUSD | 2021 Q4 |
| 11/9/2021 | 0.53USD | 2.08 BUSD | 2021 Q3 |
| 8/17/2021 | 0.47USD | 1.99 BUSD | 2021 Q2 |
| 5/4/2021 | 0.47USD | 1.95 BUSD | 2021 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Alcon stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Alcon shareholders
| % | Name |
|---|---|
4.96065% | |
4.14963% | |
2.41942% | |
2.30487% | |
2.28059% | |
2.05318% | |
1.83762% | |
1.55043% | |
1.40848% | |
1.40335% |
Alcon Executives and Management Board
Mr. David Endicott
(60)Chief Executive Officer, Director · since 2018
Mr. F. Michael Ball
(69)Non-Executive Independent Chairman of the Board · since 2016
Mr. Scott Maw
(57)Independent Director
Mr. D. Keith Grossman
(65)Independent Vice Chairman of the Board, Lead Independent Director
Mr. Thomas Glanzmann
(66)Independent Director
Alcon Supply Chain
Correlation: how closely stock prices move together
| Name | 1M | 3M | 6M | 1Y | 2Y |
|---|---|---|---|---|---|
Model N Supplier | -0,06 | 0,67 | 0,77 | 0,11 | -0,49 |
One Stop Systems Supplier | -0,18 | 0,12 | 0,49 | -0,08 | 0,54 |
inTEST Supplier | -0,03 | 0,41 | 0,60 | -0,11 | 0,69 |
IRIDEX Corp Supplier | -0,27 | 0,45 | 0,64 | 0,25 | 0,67 |
eMagin Supplier | -0,14 | 0,30 | 0,45 | -0,23 | 0,14 |
SAP Supplier | -0,03 | 0,43 | 0,55 | 0,22 | -0,18 |
Markforged Holding Supplier | -0,22 | 0,53 | 0,61 | -0,22 | — |
Tritax EuroBox Supplier | 0,17 | 0,65 | 0,71 | 0,22 | 0,74 |
-0,18 | 0,64 | 0,15 | -0,18 | 0,48 | |
-0,57 | 0,09 | 0,04 | -0,58 | — |
Alcon Research
SoonDeep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.
Research reports are coming soon
We're building institutional-grade equity research for Alcon and thousands of other companies.
Most common questions regarding Alcon
The business model of Alcon AG centers around providing innovative eye care solutions and products. As a globally recognized company, Alcon AG specializes in developing, manufacturing, and distributing a wide range of ophthalmic surgical equipment, pharmaceuticals, and consumer eye care products. Their offerings include contact lenses, surgical equipment for cataract and refractive surgeries, as well as prescription and over-the-counter eye care products. With a strong focus on research and development, Alcon AG aims to continuously improve eye health outcomes and enhance vision quality for individuals around the world.
Alcon stock
Alcon Peer Group
Alcon Ticker
Alcon FIGI
All fundamentals about Alcon
Our stock analysis for Alcon Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alcon Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.